Insider Trading History of Sanders Corazon (corsee) D.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Sanders Corazon (corsee) D. since 2023. This trader's CIK number is 1796536. At the time of last reporting, Sanders Corazon (corsee) D. was the Officer of Ultragenyx Pharmaceutical Inc.. (stock ticker symbol RARE). Also see all insider trading activities at Ultragenyx Pharmaceutical Inc..

Note that in the past Sanders Corazon (Corsee) D. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Beone Medicines Ltd. (BGNE) by Sanders Corazon (corsee) D.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 BGNE 0 $0 578 $105,020 0 $0

Yearly summary of insider trading at Ultragenyx Pharmaceutical Inc. (RARE) by Sanders Corazon (corsee) D.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 RARE 0 $0 2,405 $89,922 0 $0
2024 RARE 0 $0 584 $23,932 0 $0
2023 RARE 0 $0 2,070 $104,054 0 $0


Insider trading activities at 2 companies by Sanders Corazon (corsee) D.:

1. Beone Medicines Ltd. (BGNE)

2. Ultragenyx Pharmaceutical Inc. (RARE)

Table 1. Insider trading of Beone Medicines Ltd. (BGNE) by Sanders Corazon (corsee) D.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-06-23 BGNE Sale 578 181.70 105,020

Table 2. Insider trading of Ultragenyx Pharmaceutical Inc. (RARE) by Sanders Corazon (corsee) D.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-20 RARE Sale 2,405 37.39 89,922
2024-07-02 RARE Sale 584 40.98 23,932
2023-06-30 RARE Sale 585 46.76 27,354
2023-06-08 RARE Sale 1,485 51.65 76,700

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sanders Corazon (corsee) D. (Officer of Ultragenyx Pharmaceutical Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.